Stereotactic Body Radiotherapy (SBRT / SABR)
Ablative high-precision radiation delivering targeted tumor destruction in 1 to 5 painless outpatient sessions.
Pinpoint biological destruction of primary tumors and metastatic lesions with millimeter accuracy.
Stereotactic Body Radiotherapy (SBRT), also known as Stereotactic Ablative Radiotherapy (SABR), utilizes multiple converging beam angles to deliver very high, biologically destructive radiation doses directly to tumors while sparing adjacent healthy organs.
Completed in 1 to 5 sessions over 1 to 2 weeks (compared to traditional 5 to 7-week radiation courses), each session takes just 15 to 20 minutes on an outpatient basis without incisions, anesthesia, or hospital admission.
SBRT is standard-of-care for early-stage lung tumors, localized prostate cancer, primary liver and kidney tumors, and limited metastatic lesions in bones, spine, and lymph nodes.
Key Clinical Considerations in Your Consultation
Every recommendation is customized according to staging scans, pathology markers, and patient priorities.
Clinical candidacy evaluation across lung, prostate, liver, kidney, and bone targets
Sub-millimeter image guidance (kV-CBCT) verified before and during every beam delivery
Convenient 1 to 5-session treatment completed over 1 to 2 weeks
Non-surgical outpatient treatment allowing immediate return to daily routine
Strict dose constraints to protect critical normal organs (spinal cord, bowel, heart)
Detailed second opinion on whether SBRT is suitable for your scan reports
Discuss Stereotactic Body Radiotherapy (SBRT / SABR)
Bring biopsy reports, recent PET/CT or MRI scans, and operative summaries for a comprehensive consultation.